Europe

Foundation Medicine, Boehringer Ingelheim Collaborate on CDx for Biliary Tract Cancer Drug

PamGene, Alithea Genomics, Lausanne University get €1M for Pan-Cancer Blood Test

Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test

BioNTech, UK Government to Expand Access to Personalized mRNA Cancer Vaccines in England

In Brief This Week: Datar Cancer Genetics, Daiichi Sankyo, ProPhase Labs, Innovent Biologics

AstraZeneca to Evaluate C2i Genomics' Cancer Detection, Monitoring Platform

Tempus, AstraZeneca Collaborate on Response Biomarker Discovery for Small Cell Lung Cancer

Orano Med Commences Phase I Trial of Lead Radiopharmaceutical in GRPR-Expressing Solid Tumors

Nuvectis Partners With ENGOT, GOG Foundation on Phase Ib Ovarian Cancer Trial of HSF1 Inhibitor

Evaxion Cleared by FDA to Begin Phase IIb Trial of Cancer Vaccine, Keytruda in Melanoma

OneChain Immunotherapeutics to Launch CD1a-Targeting CAR T-Cell Therapy Trial in T-Cell Leukemia

Jazz Takes Up Option on Zymeworks' HER2-Targeted Bispecific Antibody

Multiomic Study Points to New Colorectal Cancer Risk Contributors

NICE Backs Enhertu via Managed Access Program for Certain HER2-Positive Breast Cancer Patients

AstraZeneca's Imfinzi Fails to Meet Primary Endpoint in PD-L1-high NSCLC

SeekIn Receives CE-IVD Mark for Leukemia Cancer Mutation Detection Kit

Everything Genetic, Berkshire and Surrey Pathology Services Jointly Launch Cancer NGS Service in UK

Ellipses Begins Phase I/II Trial of EP0031 in RET-Altered Tumors

Novartis' Pluvicto Approved in Europe for PSMA-Positive Castration-Resistant Prostate Cancer

Envisagenics, Cancer Research UK, Queen Mary University Collaborate on AML Drug R&D